Capital Research Global Investors Vericel Corp Transaction History
Capital Research Global Investors
- $479 Billion
- Q2 2025
A detailed history of Capital Research Global Investors transactions in Vericel Corp stock. As of the latest transaction made, Capital Research Global Investors holds 853,668 shares of VCEL stock, worth $29.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
853,668
Previous 654,461
30.44%
Holding current value
$29.6 Million
Previous $29.2 Million
24.39%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VCEL
# of Institutions
294Shares Held
54MCall Options Held
35.6KPut Options Held
7.7K-
Black Rock Inc. New York, NY8.06MShares$279 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$123 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$97.4 Million3.59% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$85.3 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$84.4 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.63B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...